Peptide usage is on the rise in Colorado. Photo by Vicky Collins

Overview:

Unapproved peptides and online GLP-1 sales are booming, but Denver-area experts warn that consumers may experience unknown long-term effects.

For decades, the idea of being fit came down to discipline surrounding diet culture and exercise. In recent years, millions of Americans have discovered synthetic peptides that can help them achieve their goals quickly and easily. 

“I’ve lost 30 pounds in the past eight weeks, and I’ve maintained all my muscle mass and have somehow gotten stronger,” said Denver resident Max Marshall, who has been taking peptides for almost two months and has seen shocking results. “The specific peptide I am taking is a GLP-1. It’s an appetite suppressant that speeds up your metabolism and slows down your digestion. It’s a perfect combo for weight loss.”

Marshall has been tracking his progress over the past 8 weeks.

“I did a body mass index, a BMI skill at my gym, and I measured the percentage of body fat in my body,” Marshall said. “I was 16% on Jan. 1, and I’m now down to 7%. I’m trying to lose weight, so being in a calorie deficit too, and not overeating, makes it really easy to do that, because you’re never thinking about food, ever.”

Max Marshall, a Denver resident, uses Retatrutide, a GLP-1 peptide, for weight loss. Photo by Brooklyn Miller

Synthetic weight-loss peptides are becoming more widely available online, often without a doctor’s consultation, raising concerns among medical professionals about their safety, regulation, and long-term effects.

Their popularity comes at a pivotal moment. Federal regulators are preparing to review whether several widely used peptides should face fewer restrictions, a move that could expand access to drugs that, in many cases, have not undergone extensive human testing. The debate underscores a growing tension between innovation and oversight in a rapidly evolving market.

What are peptides?

Although the debate over peptides is new, they are not. 

“Peptides are chains of chemically bonded amino acids,” said Nicholas Kuehl, a PhD bioconjugation process development scientist who specialized in peptides during his graduate studies and now advises Eli Lilly and Company. “As amino acids link together, they form chains, and we start to call those peptides.”

Dr. Nicholas Kuehl, a bioconjugation process development scientist. Photo courtesy of Nicholas Kuehl

Some peptide-based drugs are well established. Insulin, for example, is a peptide that has been extensively tested and safely used for decades to manage diabetes.

“There are so many different types,” said Lisa Conner, a physician assistant at Saint Joseph Hospital and Denver Health, “and they’ve evolved dramatically over time.”

But experts emphasize a critical distinction: many peptides now marketed online for weight loss, muscle growth or recovery have not undergone the same level of testing.

Why they work

Certain peptides, including GLP-1 medications, affect how the body processes food.

“They basically delay the emptying of your stomach,” Conner said. “Food sits in your stomach longer, giving you that sensation of being full and not wanting to eat.”

That mechanism has made them highly effective for weight loss and highly attractive to consumers. At the same time, researchers are exploring peptides for a wide range of medical uses beyond weight loss, including cancer treatments and hormone therapies.

“There’s a peptide that a German company actually turned into a cancer therapy by attaching it to a targeting protein, so they actually linked this toxin to a protein and enabled it to be used as a cancer therapy,” Kuehl said. “Some peptides have toxins that can be harnessed for important reasons as well.”

A fast-growing and unevenly regulated market

The surge in peptide use is partly tied to shifting federal policy. Regulators previously moved to restrict certain peptides due to safety concerns, but those decisions are now under review.

As a result, consumers are navigating a market where FDA-approved drugs exist alongside unapproved compounds sold online or through compounding pharmacies.

“When they’re just made in a compounding pharmacy, it doesn’t necessarily mean they underwent studies to prove their safety,” Conner said. “It just means that they’re made in a place that’s clean and sterile. And all the ingredients they’re putting in are supposedly pure, but that still doesn’t mean that they’ve been tested like insulin. People think if you can buy it, it must be fine, right? Scary.”

Lisa Conner is a physician assistant at Saint Joseph Hospital and Denver Health Hospital. Photo by Brooklyn Miller

The long-term effects of peptides are mostly unknown.

“I think they probably trigger unintended reactions,” Conner said. “Maybe you don’t even know you’re having a side effect, like your mood, your sleep, your skin, your blood sugar level. People don’t know. I think people just need to think long and hard about putting medicines into their bodies that have not been FDA-regulated.”

That uncertainty concerns medical professionals, particularly as more people turn to online sources that bypass traditional medical oversight. Boulder resident Madelyn Torrey said she obtained a GLP-1 drug online without consulting a doctor.

“I never had to consult a doctor,” Torrey said. “I uploaded a picture of myself standing on a scale. Then an online website sent it to me.”

While she experienced significant weight loss, the side effects were severe.

“It hurt to eat sometimes; I always tell everyone it felt like I was swallowing concrete,” Torrey said. “I was like pretty miserable the entire time I was on it; I just felt sick all the time, like I had to force myself to eat.”

Madelyn Torrey, a Boulder resident, used the GLP-1 peptide Ozempic to lose weight in 2025. Photo by Brooklyn Miller

Promise and uncertainty

For scientists, peptides represent a rapidly expanding frontier in medicine.

“All this GLP-1 stuff has only happened in the past 20 or 30 years,” Kuehl said. “In terms of human history, that’s very new.”

As research continues, peptides could unlock new treatments for a wide range of conditions. But for now, experts say the science is still catching up to the hype.

“This drug discovery is evolving as we learn to harness these compounds in new ways,” Kuehl said. “Who knows what the next peptide is going to be, right? We could find it anywhere. Nature has come up with all these different, very interesting compounds. And I think that also gives hope to the world of tomorrow, and I guess we’ll see what the future holds for peptides.”

Brooklyn Miller is a senior at the University of Colorado Boulder majoring in journalism and minoring in sociology. She is originally from Denver, Colorado, and cares deeply for her community. Brooklyn...

Leave a comment